Author
Listed:
- Sébastien Thériault
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval
Laval University)
- Nathalie Gaudreault
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Maxime Lamontagne
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Mickael Rosa
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Marie-Chloé Boulanger
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- David Messika-Zeitoun
(Bichat Hospital
INSERM U698 and University Paris 7)
- Marie-Annick Clavel
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Romain Capoulade
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- François Dagenais
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Philippe Pibarot
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Patrick Mathieu
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval)
- Yohan Bossé
(Institut universitaire de cardiologie et de pneumologie de Québec—Université Laval
Laval University)
Abstract
Calcific aortic valve stenosis (CAVS) is a common and life-threatening heart disease and the current treatment options cannot stop or delay its progression. A GWAS on 1009 cases and 1017 ethnically matched controls was combined with a large-scale eQTL mapping study of human aortic valve tissues (n = 233) to identify susceptibility genes for CAVS. Replication was performed in the UK Biobank, including 1391 cases and 352,195 controls. A transcriptome-wide association study (TWAS) reveals PALMD (palmdelphin) as significantly associated with CAVS. The CAVS risk alleles and increasing disease severity are both associated with decreased mRNA expression levels of PALMD in valve tissues. The top variant identified shows a similar effect and strong association with CAVS (P = 1.53 × 10−10) in UK Biobank. The identification of PALMD as a susceptibility gene for CAVS provides insights into the genetic nature of this disease, opens avenues to investigate its etiology and to develop much-needed therapeutic options.
Suggested Citation
Sébastien Thériault & Nathalie Gaudreault & Maxime Lamontagne & Mickael Rosa & Marie-Chloé Boulanger & David Messika-Zeitoun & Marie-Annick Clavel & Romain Capoulade & François Dagenais & Philippe Pib, 2018.
"A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis,"
Nature Communications, Nature, vol. 9(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03260-6
DOI: 10.1038/s41467-018-03260-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03260-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.